+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Fetal Alcohol Spectrum Disorder Treatment Market - Global Forecast 2026-2032- Product Image
Fetal Alcohol Spectrum Disorder Treatment Market - Global Forecast 2026-2032- Product Image
New

Fetal Alcohol Spectrum Disorder Treatment Market - Global Forecast 2026-2032

  • PDF Icon

    Report

  • 199 Pages
  • January 2026
  • Region: Global
  • 360iResearch™
  • ID: 5977881
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Across global healthcare, Fetal Alcohol Spectrum Disorder (FASD) demands a multidimensional strategy that bridges clinical care, caregiver support, and system-wide coordination. The Fetal Alcohol Spectrum Disorder Treatment Market is evolving quickly, requiring leadership attention to integrated clinical pathways and scalable operational solutions.

Market Snapshot: Fetal Alcohol Spectrum Disorder Treatment Market

The Fetal Alcohol Spectrum Disorder Treatment Market grew from USD 407.89 million in 2025 to USD 426.27 million in 2026. With an expected CAGR of 5.06%, it is projected to reach USD 576.49 million by 2032. Growth is driven by advancements in multidisciplinary service models, digital health infrastructure, and policy shifts advancing access to evidence-based care.

Scope & Segmentation

  • Treatment Types: Includes behavioral therapies (cognitive behavioral therapy, occupational therapy, and speech therapy), educational interventions (individualized education programs and specialized educational services), nutritional supplements (antioxidants, omega-3), and pharmacological treatments (neuroprotective agents, psychotropic medications).
  • End Users: Academic and research institutions, home healthcare providers, hospitals and clinics, and rehabilitation centers each serving distinctive operational models and patient groups.
  • Distribution Channels: Direct sales, hospital pharmacies, online pharmacies, and retail pharmacies influence procurement and access, with variable counseling and support touchpoints for families and caregivers.
  • Patient Age Groups: Pediatric, adolescent, and adult cohorts, each requiring unique intervention goals, ranging from developmental integration to transitional support and adult functional independence.
  • Severity Strata: Distinct categories include alcohol-related neurodevelopmental disorder, fetal alcohol syndrome, and partial fetal alcohol syndrome, which influence intervention complexity and resource allocation.
  • Regions: The Americas, Europe, Middle East & Africa, and Asia-Pacific, each distinguished by healthcare delivery systems, educational policies, and cultural factors.
  • Technologies: Integration of telehealth, digital health platforms, and cloud-native solutions to support therapy adherence and access in diverse geographies.

Key Takeaways for Senior Decision-Makers

  • Integrated care models that coordinate clinical, educational, and social supports are essential for addressing heterogenous FASD presentations and maximizing real-world functionality.
  • Technology-driven platforms and telehealth expand the reach of interventions, especially for underserved populations, and facilitate continuity between in-person and remote care.
  • Caregiver support is central: Services designed to reduce caregiver burden have been shown to improve adherence to therapy and speed developmental progress.
  • Workforce training that embeds FASD-specific competencies is critical, especially as research continues to refine treatment protocols by age group and severity.
  • Variations in healthcare infrastructure, education policy, and cultural context across regions directly influence how services are deployed and outcomes achieved.

Tariff Impact on Supply Chains and Procurement

Recent tariff measures have reshaped procurement strategies in the Fetal Alcohol Spectrum Disorder Treatment Market by affecting the pricing and availability of imported diagnostics, nutraceuticals, and digital hardware. To offset these pressures, providers have diversified suppliers, increased inventory reserves for critical products, and invested in domestic alternatives where possible. Telehealth tools and cloud-native applications, less reliant on device-specific imports, have gained traction as resilient options, supporting uninterrupted care and remote monitoring across various regions.

Research Methodology & Data Sources

This analysis utilizes peer-reviewed clinical literature, policy reviews, stakeholder interviews, and operational assessments of care models. The segmentation framework shaped data collection and validation, ensuring findings reflect sector realities and global operating contexts.

Why This Report Matters

  • Equips policymakers and administrators with actionable pathways to operationalize multidisciplinary FASD care through evidence-based and regionally-adapted models.
  • Identifies strategies to augment supply chain resilience and leverage digital platforms for therapeutic continuity.
  • Supports stakeholders in aligning reimbursement, educational objectives, and caregiver-centric service design for sustained, measurable impact.

Conclusion

This report delivers a strategic foundation for leaders aiming to advance FASD care through integrated pilots, resilient operations, and partnership-driven innovation. Actionable insights guide the adoption of multidisciplinary, scalable solutions that respond to complex stakeholder needs.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Porter’s Five Forces Analysis
4.4. PESTLE Analysis
4.5. Market Outlook
4.5.1. Near-Term Market Outlook (0-2 Years)
4.5.2. Medium-Term Market Outlook (3-5 Years)
4.5.3. Long-Term Market Outlook (5-10 Years)
4.6. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025
8. Fetal Alcohol Spectrum Disorder Treatment Market, by Treatment Type
8.1. Pharmacological Treatment
8.2. Non-Pharmacological Treatment
8.3. Combination Therapy
8.4. Supportive And Adjunctive Services
9. Fetal Alcohol Spectrum Disorder Treatment Market, by Drug Class
9.1. Stimulants
9.2. Antidepressants
9.3. Antipsychotics
9.4. Anticonvulsants
9.5. Anxiolytics
9.6. Sleep Agents
9.7. Nutritional Supplements
9.7.1. Choline Supplements
9.7.2. Omega-3 Fatty Acids
9.7.3. Vitamins And Minerals
10. Fetal Alcohol Spectrum Disorder Treatment Market, by Spectrum Disorder Type
10.1. Fetal Alcohol Syndrome
10.2. Partial Fetal Alcohol Syndrome
10.3. Alcohol-Related Neurodevelopmental Disorder
10.4. Alcohol-Related Birth Defects
10.5. Neurobehavioral Disorder Associated With Prenatal Alcohol Exposure
11. Fetal Alcohol Spectrum Disorder Treatment Market, by End User
11.1. Hospitals
11.2. Specialty Clinics
11.3. Rehabilitation Centers
11.4. Research And Academic Institutes
11.5. Non-Governmental And Community Organizations
11.6. Individual Patients And Caregivers
12. Fetal Alcohol Spectrum Disorder Treatment Market, by Region
12.1. Americas
12.1.1. North America
12.1.2. Latin America
12.2. Europe, Middle East & Africa
12.2.1. Europe
12.2.2. Middle East
12.2.3. Africa
12.3. Asia-Pacific
13. Fetal Alcohol Spectrum Disorder Treatment Market, by Group
13.1. ASEAN
13.2. GCC
13.3. European Union
13.4. BRICS
13.5. G7
13.6. NATO
14. Fetal Alcohol Spectrum Disorder Treatment Market, by Country
14.1. United States
14.2. Canada
14.3. Mexico
14.4. Brazil
14.5. United Kingdom
14.6. Germany
14.7. France
14.8. Russia
14.9. Italy
14.10. Spain
14.11. China
14.12. India
14.13. Japan
14.14. Australia
14.15. South Korea
15. United States Fetal Alcohol Spectrum Disorder Treatment Market
16. China Fetal Alcohol Spectrum Disorder Treatment Market
17. Competitive Landscape
17.1. Market Concentration Analysis, 2025
17.1.1. Concentration Ratio (CR)
17.1.2. Herfindahl Hirschman Index (HHI)
17.2. Recent Developments & Impact Analysis, 2025
17.3. Product Portfolio Analysis, 2025
17.4. Benchmarking Analysis, 2025
17.5. Elemeno Health Inc.
17.6. Eli Lilly and Company
17.7. Johnson & Johnson Services, Inc.
17.8. Mikhalia Therapeutics Inc.
17.9. Mikhalia Therapeutics Inc.
17.10. Novartis AG
17.11. Pfizer Inc.
17.12. Roche Holding AG
17.13. Sanofi
17.14. Therapeutics Development Company Ltd.
17.15. Therapeutics Development Company Ltd.
List of Figures
FIGURE 1. GLOBAL FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 2. GLOBAL FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 3. GLOBAL FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET, FPNV POSITIONING MATRIX, 2025
FIGURE 4. GLOBAL FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 5. GLOBAL FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY DRUG CLASS, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 6. GLOBAL FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY SPECTRUM DISORDER TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 7. GLOBAL FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 9. GLOBAL FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 11. UNITED STATES FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 12. CHINA FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, 2018-2032 (USD MILLION)
List of Tables
TABLE 1. GLOBAL FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 2. GLOBAL FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY PHARMACOLOGICAL TREATMENT, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY PHARMACOLOGICAL TREATMENT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY PHARMACOLOGICAL TREATMENT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY NON-PHARMACOLOGICAL TREATMENT, BY REGION, 2018-2032 (USD MILLION)
TABLE 7. GLOBAL FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY NON-PHARMACOLOGICAL TREATMENT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 8. GLOBAL FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY NON-PHARMACOLOGICAL TREATMENT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY COMBINATION THERAPY, BY REGION, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY COMBINATION THERAPY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY COMBINATION THERAPY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY SUPPORTIVE AND ADJUNCTIVE SERVICES, BY REGION, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY SUPPORTIVE AND ADJUNCTIVE SERVICES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY SUPPORTIVE AND ADJUNCTIVE SERVICES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY STIMULANTS, BY REGION, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY STIMULANTS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY STIMULANTS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY ANTIDEPRESSANTS, BY REGION, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY ANTIDEPRESSANTS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY ANTIDEPRESSANTS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY ANTIPSYCHOTICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY ANTIPSYCHOTICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY ANTIPSYCHOTICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY ANTICONVULSANTS, BY REGION, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY ANTICONVULSANTS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY ANTICONVULSANTS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY ANXIOLYTICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY ANXIOLYTICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY ANXIOLYTICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY SLEEP AGENTS, BY REGION, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY SLEEP AGENTS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY SLEEP AGENTS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY NUTRITIONAL SUPPLEMENTS, BY REGION, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY NUTRITIONAL SUPPLEMENTS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY NUTRITIONAL SUPPLEMENTS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY NUTRITIONAL SUPPLEMENTS, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY CHOLINE SUPPLEMENTS, BY REGION, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY CHOLINE SUPPLEMENTS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY CHOLINE SUPPLEMENTS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY OMEGA-3 FATTY ACIDS, BY REGION, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY OMEGA-3 FATTY ACIDS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY OMEGA-3 FATTY ACIDS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY VITAMINS AND MINERALS, BY REGION, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY VITAMINS AND MINERALS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY VITAMINS AND MINERALS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY SPECTRUM DISORDER TYPE, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY FETAL ALCOHOL SYNDROME, BY REGION, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY FETAL ALCOHOL SYNDROME, BY GROUP, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY FETAL ALCOHOL SYNDROME, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY PARTIAL FETAL ALCOHOL SYNDROME, BY REGION, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY PARTIAL FETAL ALCOHOL SYNDROME, BY GROUP, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY PARTIAL FETAL ALCOHOL SYNDROME, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY ALCOHOL-RELATED NEURODEVELOPMENTAL DISORDER, BY REGION, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY ALCOHOL-RELATED NEURODEVELOPMENTAL DISORDER, BY GROUP, 2018-2032 (USD MILLION)
TABLE 56. GLOBAL FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY ALCOHOL-RELATED NEURODEVELOPMENTAL DISORDER, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 57. GLOBAL FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY ALCOHOL-RELATED BIRTH DEFECTS, BY REGION, 2018-2032 (USD MILLION)
TABLE 58. GLOBAL FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY ALCOHOL-RELATED BIRTH DEFECTS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 59. GLOBAL FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY ALCOHOL-RELATED BIRTH DEFECTS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 60. GLOBAL FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY NEUROBEHAVIORAL DISORDER ASSOCIATED WITH PRENATAL ALCOHOL EXPOSURE, BY REGION, 2018-2032 (USD MILLION)
TABLE 61. GLOBAL FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY NEUROBEHAVIORAL DISORDER ASSOCIATED WITH PRENATAL ALCOHOL EXPOSURE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 62. GLOBAL FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY NEUROBEHAVIORAL DISORDER ASSOCIATED WITH PRENATAL ALCOHOL EXPOSURE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 63. GLOBAL FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 64. GLOBAL FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
TABLE 65. GLOBAL FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 66. GLOBAL FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 67. GLOBAL FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 68. GLOBAL FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY SPECIALTY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 69. GLOBAL FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY SPECIALTY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 70. GLOBAL FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY REHABILITATION CENTERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 71. GLOBAL FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY REHABILITATION CENTERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 72. GLOBAL FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY REHABILITATION CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 73. GLOBAL FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY RESEARCH AND ACADEMIC INSTITUTES, BY REGION, 2018-2032 (USD MILLION)
TABLE 74. GLOBAL FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY RESEARCH AND ACADEMIC INSTITUTES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 75. GLOBAL FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY RESEARCH AND ACADEMIC INSTITUTES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 76. GLOBAL FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY NON-GOVERNMENTAL AND COMMUNITY ORGANIZATIONS, BY REGION, 2018-2032 (USD MILLION)
TABLE 77. GLOBAL FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY NON-GOVERNMENTAL AND COMMUNITY ORGANIZATIONS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 78. GLOBAL FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY NON-GOVERNMENTAL AND COMMUNITY ORGANIZATIONS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 79. GLOBAL FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY INDIVIDUAL PATIENTS AND CAREGIVERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 80. GLOBAL FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY INDIVIDUAL PATIENTS AND CAREGIVERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 81. GLOBAL FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY INDIVIDUAL PATIENTS AND CAREGIVERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 82. GLOBAL FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 83. AMERICAS FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 84. AMERICAS FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
TABLE 85. AMERICAS FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 86. AMERICAS FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY NUTRITIONAL SUPPLEMENTS, 2018-2032 (USD MILLION)
TABLE 87. AMERICAS FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY SPECTRUM DISORDER TYPE, 2018-2032 (USD MILLION)
TABLE 88. AMERICAS FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 89. NORTH AMERICA FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 90. NORTH AMERICA FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
TABLE 91. NORTH AMERICA FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 92. NORTH AMERICA FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY NUTRITIONAL SUPPLEMENTS, 2018-2032 (USD MILLION)
TABLE 93. NORTH AMERICA FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY SPECTRUM DISORDER TYPE, 2018-2032 (USD MILLION)
TABLE 94. NORTH AMERICA FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 95. LATIN AMERICA FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 96. LATIN AMERICA FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
TABLE 97. LATIN AMERICA FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 98. LATIN AMERICA FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY NUTRITIONAL SUPPLEMENTS, 2018-2032 (USD MILLION)
TABLE 99. LATIN AMERICA FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY SPECTRUM DISORDER TYPE, 2018-2032 (USD MILLION)
TABLE 100. LATIN AMERICA FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 101. EUROPE, MIDDLE EAST & AFRICA FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 102. EUROPE, MIDDLE EAST & AFRICA FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
TABLE 103. EUROPE, MIDDLE EAST & AFRICA FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 104. EUROPE, MIDDLE EAST & AFRICA FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY NUTRITIONAL SUPPLEMENTS, 2018-2032 (USD MILLION)
TABLE 105. EUROPE, MIDDLE EAST & AFRICA FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY SPECTRUM DISORDER TYPE, 2018-2032 (USD MILLION)
TABLE 106. EUROPE, MIDDLE EAST & AFRICA FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 107. EUROPE FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 108. EUROPE FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
TABLE 109. EUROPE FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 110. EUROPE FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY NUTRITIONAL SUPPLEMENTS, 2018-2032 (USD MILLION)
TABLE 111. EUROPE FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY SPECTRUM DISORDER TYPE, 2018-2032 (USD MILLION)
TABLE 112. EUROPE FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 113. MIDDLE EAST FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 114. MIDDLE EAST FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
TABLE 115. MIDDLE EAST FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 116. MIDDLE EAST FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY NUTRITIONAL SUPPLEMENTS, 2018-2032 (USD MILLION)
TABLE 117. MIDDLE EAST FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY SPECTRUM DISORDER TYPE, 2018-2032 (USD MILLION)
TABLE 118. MIDDLE EAST FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 119. AFRICA FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 120. AFRICA FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
TABLE 121. AFRICA FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 122. AFRICA FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY NUTRITIONAL SUPPLEMENTS, 2018-2032 (USD MILLION)
TABLE 123. AFRICA FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY SPECTRUM DISORDER TYPE, 2018-2032 (USD MILLION)
TABLE 124. AFRICA FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 125. ASIA-PACIFIC FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 126. ASIA-PACIFIC FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
TABLE 127. ASIA-PACIFIC FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 128. ASIA-PACIFIC FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY NUTRITIONAL SUPPLEMENTS, 2018-2032 (USD MILLION)
TABLE 129. ASIA-PACIFIC FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY SPECTRUM DISORDER TYPE, 2018-2032 (USD MILLION)
TABLE 130. ASIA-PACIFIC FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 131. GLOBAL FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 132. ASEAN FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 133. ASEAN FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
TABLE 134. ASEAN FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 135. ASEAN FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY NUTRITIONAL SUPPLEMENTS, 2018-2032 (USD MILLION)
TABLE 136. ASEAN FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY SPECTRUM DISORDER TYPE, 2018-2032 (USD MILLION)
TABLE 137. ASEAN FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 138. GCC FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 139. GCC FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
TABLE 140. GCC FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 141. GCC FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY NUTRITIONAL SUPPLEMENTS, 2018-2032 (USD MILLION)
TABLE 142. GCC FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY SPECTRUM DISORDER TYPE, 2018-2032 (USD MILLION)
TABLE 143. GCC FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 144. EUROPEAN UNION FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 145. EUROPEAN UNION FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
TABLE 146. EUROPEAN UNION FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 147. EUROPEAN UNION FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY NUTRITIONAL SUPPLEMENTS, 2018-2032 (USD MILLION)
TABLE 148. EUROPEAN UNION FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY SPECTRUM DISORDER TYPE, 2018-2032 (USD MILLION)
TABLE 149. EUROPEAN UNION FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 150. BRICS FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 151. BRICS FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
TABLE 152. BRICS FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 153. BRICS FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY NUTRITIONAL SUPPLEMENTS, 2018-2032 (USD MILLION)
TABLE 154. BRICS FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY SPECTRUM DISORDER TYPE, 2018-2032 (USD MILLION)
TABLE 155. BRICS FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 156. G7 FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 157. G7 FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
TABLE 158. G7 FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 159. G7 FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY NUTRITIONAL SUPPLEMENTS, 2018-2032 (USD MILLION)
TABLE 160. G7 FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY SPECTRUM DISORDER TYPE, 2018-2032 (USD MILLION)
TABLE 161. G7 FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 162. NATO FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 163. NATO FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
TABLE 164. NATO FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 165. NATO FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY NUTRITIONAL SUPPLEMENTS, 2018-2032 (USD MILLION)
TABLE 166. NATO FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY SPECTRUM DISORDER TYPE, 2018-2032 (USD MILLION)
TABLE 167. NATO FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 168. GLOBAL FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 169. UNITED STATES FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 170. UNITED STATES FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
TABLE 171. UNITED STATES FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 172. UNITED STATES FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY NUTRITIONAL SUPPLEMENTS, 2018-2032 (USD MILLION)
TABLE 173. UNITED STATES FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY SPECTRUM DISORDER TYPE, 2018-2032 (USD MILLION)
TABLE 174. UNITED STATES FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 175. CHINA FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 176. CHINA FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
TABLE 177. CHINA FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 178. CHINA FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY NUTRITIONAL SUPPLEMENTS, 2018-2032 (USD MILLION)
TABLE 179. CHINA FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY SPECTRUM DISORDER TYPE, 2018-2032 (USD MILLION)
TABLE 180. CHINA FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)

Companies Mentioned

The key companies profiled in this Fetal Alcohol Spectrum Disorder Treatment market report include:
  • Elemeno Health Inc.
  • Eli Lilly and Company
  • Johnson & Johnson Services, Inc.
  • Mikhalia Therapeutics Inc.
  • Mikhalia Therapeutics Inc.
  • Novartis AG
  • Pfizer Inc.
  • Roche Holding AG
  • Sanofi
  • Therapeutics Development Company Ltd.
  • Therapeutics Development Company Ltd.

Table Information

Report AttributeDetails
No. of Pages199
PublishedJanuary 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 426.27 Million
Forecasted Market Value ( USD ) by 2032 $ 576.49 Million
Compound Annual Growth Rate5.0%
Regions CoveredGlobal
No. of Companies Mentioned12

Related Topics

Related Reports

Neuroscience of Alcohol. Mechanisms and Treatment - Product Image

Neuroscience of Alcohol. Mechanisms and Treatment

  • Book
The Assessment and Treatment of Addiction. Best Practices and New Frontiers - Product Image

The Assessment and Treatment of Addiction. Best Practices and New Frontiers

  • Book
Alcohol Use Disorder Market - Global Forecast 2026-2032 - Product Image

Alcohol Use Disorder Market - Global Forecast 2026-2032

  • Report
  • 186 Pages
  • Global
From
Medications for Alcohol Use Disorder Market - Global Forecast 2026-2032 - Product Image

Medications for Alcohol Use Disorder Market - Global Forecast 2026-2032

  • Report
  • 187 Pages
  • Global
From
Alcohol Use Disorder Market Report and Forecast 2025-2034 - Product Image

Alcohol Use Disorder Market Report and Forecast 2025-2034

  • Report
  • 400 Pages
  • Global
From

About the Market

Fetal Alcohol Syndrome (FAS) Drugs are a type of Central Nervous System (CNS) Drugs used to treat the physical and mental effects of prenatal alcohol exposure. These drugs are used to reduce the severity of physical and mental disabilities caused by FAS, such as facial deformities, growth deficiencies, and cognitive and behavioral problems. FAS Drugs are typically prescribed to pregnant women and infants, and may include medications to treat seizures, anxiety, and depression. FAS Drugs are a relatively new class of CNS Drugs, and research is ongoing to develop more effective treatments. Currently, there are no approved drugs specifically for FAS, but some medications used to treat other CNS conditions may be used off-label to treat FAS. Some companies in the Fetal Alcohol Syndrome Drugs market include Pfizer, GlaxoSmithKline, Merck, and Novartis. Show Less Read more

Copyright © 2002-2026 Research and Markets. All Rights Reserved.